Related Experiment Videos

Factors affecting length of stay in the pediatric emergency department

Sung-Tse Li1, Nan-Chang Chiu, Wen-Chuan Kung

  • 1Department of Pediatrics, Hsinchu Mackay Memorial Hospital, Hsinchu, Taiwan. a4521@ms7.mmh.org.tw

Insights

This study analyzed pediatric emergency department (ED) length of stay (LOS), finding that shorter waiting times for admission and fewer laboratory tests significantly reduce patient LOS.

Area of Science:

  • Pediatric Emergency Medicine
  • Healthcare Operations Research

Background:

  • Emergency department (ED) overcrowding is a significant issue, leading to prolonged length of stay (LOS).
  • Understanding factors influencing LOS in pediatric EDs is crucial for improving patient flow and care quality.

Purpose of the Study:

  • To identify and analyze key factors affecting the length of stay (LOS) for patients in a pediatric emergency department (ED).

Main Methods:

  • Retrospective analysis of 29,035 patient visits to a pediatric ED from July 2006 to June 2007.
  • Utilized eta-squared correlation ratio and Cramer's V test to assess variable associations.
  • Employed a classification and regression tree (CART) model for analysis, with data split into training (two-thirds) and validation (one-third) sets.

Main Results:

  • Fever was the primary reason for visits (61.1%).
  • The mean LOS was 2.6 ± 4.67 hours, with 74.3% of visits under 2 hours.
  • CART analysis identified five key factors influencing LOS, creating nine distinct patient subgroups.

Conclusions:

  • Shortest LOS was associated with waiting less than 8 hours for hospitalization, no admission, no laboratory tests, door-to-physician time under 60 minutes, and absence of gastrointestinal symptoms.
  • Patients waiting over 16 hours for hospitalization experienced the longest LOS.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...